SGLT-2 Inhibitors: Fighting Cardiovascular Disease Mortality in Diabetes

被引：0
|
作者：
Ghaffar, Zunaira Abdul
Anwar, Shahzad
Rizvi, Syed Wajih
机构：
[1] Dow Univ Hlth Sci, Dept Med, Dow Med Coll, Karachi, Pakistan
[2] Univ Med & Dent, Camden, NJ USA
来源：
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2019年 / 29卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：195 / 195
页数：1
相关论文
共 50 条
  • [41] SGLT-2 inhibitors: Diabetes and CKD and CHF (and gout?), oh my!
    Mandell, Brian F.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2024, 91 (07) : 392 - 393
  • [42] Cerebrovascular Complications of Diabetes: SGLT-2 Inhibitors as a Promising Future Therapeutics
    Chavda, Vishal
    Vashi, Ruju
    Patel, Snehal
    CURRENT DRUG TARGETS, 2021, 22 (14) : 1629 - 1636
  • [43] SGLT-2 inhibitors as adjunctive to insulin therapy in type 1 diabetes
    Maj-Podsiadlo, Anna
    Cichocka, Edyta
    Gumprecht, Janusz
    CLINICAL DIABETOLOGY, 2020, 9 (03): : 189 - 192
  • [44] SGLT-2 Inhibitors: Is There a Role in Type 1 Diabetes Mellitus Management?
    Ahmed-Sarwar, Nabila
    Nagel, Angela K.
    Leistman, Samantha
    Heacock, Kevin
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (09) : 791 - 796
  • [45] TYPE 1 DIABETES: IMPACT OF SGLT-2 INHIBITORS ON GLYCEMIC CONTROL
    Lavrador, M.
    Araujo, B.
    Araujo, C.
    Melo, M.
    Baptista, C.
    Barros, L.
    Paiva, I.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A181 - A181
  • [46] Diabetes mellitus: Does SGLT-2 Inhibitors increase the Risk of Amputation?
    Gallwitz, Baptist
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (06) : 366 - +
  • [47] EUGLYCEMIC DKA WITH SGLT-2 INHIBITORS
    Zuniga, Eric
    Lee, Emily
    Daniel, Raeye
    Zhou, Leon
    Vaidya, Ajay
    Alderwish, Edris
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2981 - 2981
  • [48] Overview of the Efficacy and Safety of SGLT-2 Inhibitors in Type 2 Diabetes Mellitus
    Miller, Eden M.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (02): : S5 - S12
  • [49] Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus: focus on SGLT-2 inhibitors and GLP-1 receptor agonists
    Bonaventura, A.
    Carbone, S.
    Dixon, D. L.
    Abbate, A.
    Montecucco, F.
    JOURNAL OF INTERNAL MEDICINE, 2019, 286 (01) : 16 - 31
  • [50] SGLT-2 inhibitors as second-line therapy in type 2 diabetes
    Tahrani, Abd A.
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (09): : 678 - 679
12345